lastacaft

Generic: alcaftadine

Labeler: allergan, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name lastacaft
Generic Name alcaftadine
Labeler allergan, inc.
Dosage Form SOLUTION/ DROPS
Routes
OPHTHALMIC
Active Ingredients

alcaftadine 2.5 mg/mL

Manufacturer
Allergan, Inc.

Identifiers & Regulatory

Product NDC 0023-4290
Product ID 0023-4290_03500b7d-f60e-44a0-b57e-5030a35c82aa
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA022134
Listing Expiration 2026-12-31
Marketing Start 2010-11-01

Pharmacologic Class

Established (EPC)
histamine-1 receptor antagonist [epc]
Mechanism of Action
histamine h1 receptor antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00234290
Hyphenated Format 0023-4290

Supplemental Identifiers

RxCUI
1000085 1000089
UPC
0300234290032
UNII
7Z8O94ECSX
NUI
N0000000190 N0000175587

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lastacaft (source: ndc)
Generic Name alcaftadine (source: ndc)
Application Number NDA022134 (source: ndc)
Routes
OPHTHALMIC
source: ndc

Resolved Composition

Strengths
  • 2.5 mg/mL
source: ndc
Packaging
  • 1 BOTTLE, PLASTIC in 1 CARTON (0023-4290-01) / 1 mL in 1 BOTTLE, PLASTIC
source: ndc

Packages (1)

Ingredients (1)

alcaftadine (2.5 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["OPHTHALMIC"], "spl_id": "03500b7d-f60e-44a0-b57e-5030a35c82aa", "openfda": {"nui": ["N0000000190", "N0000175587"], "upc": ["0300234290032"], "unii": ["7Z8O94ECSX"], "rxcui": ["1000085", "1000089"], "spl_set_id": ["17d37e8d-7825-424b-b6ca-0a85d0bf4694"], "pharm_class_epc": ["Histamine-1 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Histamine H1 Receptor Antagonists [MoA]"], "manufacturer_name": ["Allergan, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (0023-4290-01)  / 1 mL in 1 BOTTLE, PLASTIC", "package_ndc": "0023-4290-01", "marketing_start_date": "20101101"}], "brand_name": "LASTACAFT", "product_id": "0023-4290_03500b7d-f60e-44a0-b57e-5030a35c82aa", "dosage_form": "SOLUTION/ DROPS", "pharm_class": ["Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]"], "product_ndc": "0023-4290", "generic_name": "alcaftadine", "labeler_name": "Allergan, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LASTACAFT", "active_ingredients": [{"name": "ALCAFTADINE", "strength": "2.5 mg/mL"}], "application_number": "NDA022134", "marketing_category": "NDA", "marketing_start_date": "20101101", "listing_expiration_date": "20261231"}